OTC Markets OTCPK - Delayed Quote USD
Reflect Scientific, Inc. (RSCF)
0.0600
0.0000
(0.00%)
At close: June 12 at 8:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,721.6180
1,080.1540
2,041.2970
2,814.6700
2,792.6230
Cost of Revenue
715.0390
483.7330
822.1470
884.0660
1,071.3210
Gross Profit
1,006.5790
596.4210
1,219.1500
1,930.6040
1,721.3020
Operating Expense
1,069.0600
1,063.6990
1,129.0520
1,102.8040
1,070.2970
Operating Income
-62.4810
-467.2780
90.0980
827.8000
651.0050
Net Non Operating Interest Income Expense
--
--
--
0
-0.8900
Other Income Expense
33.1620
8.5620
--
111.2650
10
Pretax Income
-29.3190
-458.7160
90.0980
939.0650
660.1150
Tax Provision
0.1000
0.3120
0.7020
0
0
Net Income Common Stockholders
-29.4190
-459.0280
89.3960
939.0650
660.1150
Diluted NI Available to Com Stockholders
-29.4190
-459.0280
89.3960
939.0650
660.1150
Basic EPS
-0.00
-0.01
0.00
0.01
0.01
Diluted EPS
-0.00
-0.01
0.00
0.01
0.01
Basic Average Shares
85,555.2850
85,217.7850
84,990.9350
84,739.7700
84,739.0860
Diluted Average Shares
85,555.2850
85,217.7850
85,440.9350
85,489.7700
84,739.0860
Total Operating Income as Reported
-62.4810
-467.2780
90.0980
827.8000
651.0050
Total Expenses
1,784.0990
1,547.4320
1,951.1990
1,986.8700
2,141.6180
Net Income from Continuing & Discontinued Operation
-29.4190
-459.0280
89.3960
939.0650
660.1150
Normalized Income
-29.4190
-459.0280
89.3960
827.8000
660.1150
Interest Expense
--
--
--
0
0.8900
Net Interest Income
--
--
--
0
-0.8900
EBIT
-62.4810
-467.2780
90.0980
827.8000
661.0050
EBITDA
8.8560
-405.7840
146.3160
884.9580
723.3460
Reconciled Cost of Revenue
715.0390
483.7330
822.1470
884.0660
1,071.3210
Reconciled Depreciation
71.3370
61.4940
56.2180
57.1580
62.3410
Net Income from Continuing Operation Net Minority Interest
-29.4190
-459.0280
89.3960
939.0650
660.1150
Total Unusual Items Excluding Goodwill
-111.2650
--
0
111.2650
--
Total Unusual Items
-111.2650
--
0
111.2650
--
Normalized EBITDA
8.8560
-405.7840
146.3160
773.6930
723.3460
Tax Rate for Calcs
0.0002
0.0002
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2020 - 5/1/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
YBGJ Yubo International Biotech Limited
0.0756
0.00%
RVP Retractable Technologies, Inc.
0.6510
-5.90%
MHUA Meihua International Medical Technologies Co., Ltd.
0.3407
-10.34%
INND InnerScope Hearing Technologies, Inc.
0.0038
-5.00%
GCTK GlucoTrack, Inc.
0.0949
-10.39%
STSS Sharps Technology, Inc.
5.45
-7.47%
COO The Cooper Companies, Inc.
69.70
-1.66%
ISRG Intuitive Surgical, Inc.
512.18
-0.16%